Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 6
1991 9
1992 13
1993 29
1994 30
1995 30
1996 44
1997 65
1998 55
1999 63
2000 75
2001 96
2002 103
2003 107
2004 123
2005 126
2006 123
2007 139
2008 131
2009 147
2010 134
2011 128
2012 135
2013 147
2014 126
2015 142
2016 159
2017 143
2018 132
2019 138
2020 136
2021 122
2022 106
2023 122
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

3,087 results

Results by year

Citations

4 articles found by citation matching
Show all

Search results

Filters applied: . Clear all
Page 1
Coronary In-Stent Restenosis: Predictors and Treatment.
Ullrich H, Olschewski M, Münzel T, Gori T. Ullrich H, et al. Dtsch Arztebl Int. 2021 Sep 24;118(38):637-644. doi: 10.3238/arztebl.m2021.0254. Dtsch Arztebl Int. 2021. PMID: 34379053 Free PMC article. Review.
BACKGROUND: Despite the use of modern drug-eluting stents (DES), in-stent restenosis (ISR) may still occur in as many as 2-10% of percutaneous coronary interventions (PCI) in certain lesion/patient subsets. ...Compared to de novo stenosis, patie …
BACKGROUND: Despite the use of modern drug-eluting stents (DES), in-stent restenosis (ISR) may still occur in as many as 2-10% …
Outcomes of Percutaneous Coronary Intervention for In-Stent Restenosis Versus De Novo Lesions: A Meta-Analysis.
Elbadawi A, Dang AT, Mahana I, Elzeneini M, Alonso F, Banerjee S, Kumbhani DJ, Elgendy IY, Mintz GS. Elbadawi A, et al. J Am Heart Assoc. 2023 Jul 4;12(13):e029300. doi: 10.1161/JAHA.122.029300. Epub 2023 Jun 29. J Am Heart Assoc. 2023. PMID: 37382147 Free PMC article.
Background In-stent restenosis (ISR) is commonly encountered even in the era of contemporary percutaneous coronary intervention (PCI). ...PCI for ISR was associated with a higher incidence of all-cause mortality (OR, 1.03 [95% CI, 1.02-1.04]), myocardi …
Background In-stent restenosis (ISR) is commonly encountered even in the era of contemporary percutaneous coronary i …
Physiological assessment after percutaneous coronary intervention: the hard truth.
Zimbardo G, Cialdella P, DI Giusto F, Migliaro S, Anastasia G, Petrolati E, Galante D, D'Amario D, Leone AM. Zimbardo G, et al. Panminerva Med. 2021 Dec;63(4):519-528. doi: 10.23736/S0031-0808.21.04363-9. Epub 2021 Sep 6. Panminerva Med. 2021. PMID: 34486363 Review.
Physiologically guided revascularization, using fractional flow reserve (FFR) or instantaneous wave free ratio (iFR) has been demonstrated to be associated with better long-term outcomes compared to an angiographically-guided strategy, mainly avoiding inappropriate coronary …
Physiologically guided revascularization, using fractional flow reserve (FFR) or instantaneous wave free ratio (iFR) has been demonstrated t …
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease.
Hill JM, Kereiakes DJ, Shlofmitz RA, Klein AJ, Riley RF, Price MJ, Herrmann HC, Bachinsky W, Waksman R, Stone GW; Disrupt CAD III Investigators. Hill JM, et al. J Am Coll Cardiol. 2020 Dec 1;76(22):2635-2646. doi: 10.1016/j.jacc.2020.09.603. Epub 2020 Oct 15. J Am Coll Cardiol. 2020. PMID: 33069849 Free article. Clinical Trial.
BACKGROUND: Coronary calcification hinders stent delivery and expansion and is associated with adverse outcomes. ...CONCLUSIONS: Coronary IVL safely and effectively facilitated stent implantation in severely calcified lesions....
BACKGROUND: Coronary calcification hinders stent delivery and expansion and is associated with adverse outcomes. ...CONCLUSION …
In-Stent Restenosis.
Kawai K, Virmani R, Finn AV. Kawai K, et al. Interv Cardiol Clin. 2022 Oct;11(4):429-443. doi: 10.1016/j.iccl.2022.02.005. Epub 2022 Sep 24. Interv Cardiol Clin. 2022. PMID: 36243488 Review.
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary intervention, even in the era of drug-eluting stents, and its treatment remains suboptimal. Neoatherosclerosis is an important component of the pathology of I …
In-stent restenosis (ISR) remains a potential complication after percutaneous coronary intervention, even in the …
Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.
Siontis GC, Stefanini GG, Mavridis D, Siontis KC, Alfonso F, Pérez-Vizcayno MJ, Byrne RA, Kastrati A, Meier B, Salanti G, Jüni P, Windecker S. Siontis GC, et al. Lancet. 2015 Aug 15;386(9994):655-64. doi: 10.1016/S0140-6736(15)60657-2. Lancet. 2015. PMID: 26334160 Review.
BACKGROUND: Percutaneous coronary intervention (PCI) with drug-eluting stents is the standard of care for treatment of native coronary artery stenoses, but optimum treatment strategies for bare metal stent and drug-eluting stent in …
BACKGROUND: Percutaneous coronary intervention (PCI) with drug-eluting stents is the standard of care for treatm …
Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
Wallner K, Kearney KE, Kim M, Tiwana J, Elison D, Kim EY, Parvathaneni U, Lombardi WL, Phillips ML, Don C. Wallner K, et al. Catheter Cardiovasc Interv. 2022 Nov;100(5):759-762. doi: 10.1002/ccd.30399. Epub 2022 Sep 13. Catheter Cardiovasc Interv. 2022. PMID: 36098336 Review.
Previous investigations described mostly discrete, focal recurrences, typically at the proximal or distal edges of the irradiated segment after plain angioplasty or bare metal stents. We reviewed failure patterns of 30 unselected drug-eluting stent (DES) patients wh …
Previous investigations described mostly discrete, focal recurrences, typically at the proximal or distal edges of the irradiated segment af …
Coronary bypass graft perforation during percutaneous intervention.
Chowdhury MA, Sheikh MA. Chowdhury MA, et al. Cardiovasc Revasc Med. 2016 Jan-Feb;17(1):48-53. doi: 10.1016/j.carrev.2015.11.004. Epub 2015 Nov 26. Cardiovasc Revasc Med. 2016. PMID: 26831902 Review.
INTRODUCTION: Coronary artery bypass grafts are prone to accelerated atherosclerosis and as such graft stenosis is frequently encountered in clinical practice. ...Majority of cases reported using covered stents (81%). Average stent diameter of 3.90.7mm …
INTRODUCTION: Coronary artery bypass grafts are prone to accelerated atherosclerosis and as such graft stenosis is frequently …
The impact of left circumflex coronary artery ostium stenosis on outcomes for patients after percutaneous coronary intervention for unprotected left main disease.
Skorupski WJ, Kałużna-Oleksy M, Mitkowski P, Araszkiewicz A, Skorupski W, Grajek S, Pyda M, Lesiak M, Grygier M. Skorupski WJ, et al. Kardiol Pol. 2023;81(9):903-908. doi: 10.33963/KP.a2023.0156. Epub 2023 Jul 25. Kardiol Pol. 2023. PMID: 37489824 Free article.
AIM: The study aimed to assess whether the involvement of LCX ostium carries prognostic implications in patients undergoing unprotected LM percutaneous coronary intervention (PCI). METHODS: Consecutive 564 patients with unprotected LM (ULMCA) disease who unde …
AIM: The study aimed to assess whether the involvement of LCX ostium carries prognostic implications in patients undergoing unprotected LM …
3,087 results